Related Experiment Videos

Penicillin tolerance of human isolates of group C streptococci

Insights

Penicillin tolerance is common in group C streptococci infections. Combining penicillin with gentamicin effectively kills these bacteria, suggesting a better treatment approach for serious infections.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Pharmacology

Background:

  • Group C streptococci are significant human pathogens.
  • Penicillin is a primary antibiotic for streptococcal infections.
  • Previous studies have not fully characterized penicillin tolerance in group C streptococci.

Purpose of the Study:

  • To investigate the prevalence of penicillin tolerance in clinical isolates of group C streptococci.
  • To evaluate the synergistic effect of penicillin and gentamicin against these strains.
  • To assess the bactericidal activity of the combination therapy.

Main Methods:

  • Testing 17 clinical isolates of group C streptococci for penicillin tolerance.
  • Determining the minimal inhibitory concentration (MIC) and minimal bactericidal concentration (MBC).
  • Evaluating the synergistic activity of penicillin and gentamicin in vitro.
  • Measuring the rate of bacterial killing using time-kill assays.

Main Results:

  • Sixteen out of 17 isolates (94%) exhibited penicillin tolerance (MIC/MBC ratio ≥ 32).
  • Penicillin and gentamicin demonstrated synergistic killing of all tested strains.
  • The combination therapy eradicated all isolates within 5 hours, while monotherapy failed within 48 hours.

Conclusions:

  • Penicillin tolerance is a frequent characteristic of group C streptococci.
  • The combination of penicillin and gentamicin offers a potent bactericidal effect.
  • This synergy may explain treatment failures with penicillin monotherapy in severe group C streptococcal infections.

Related Concept Videos